Article
Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer.
Molecular cancer therapeutics - 1 Oct 2015
Stintzing Sebastian, Zhang Wu, Heinemann Volker, Neureiter Daniel, Kemmerling Ralf, Kirchner Thomas, Jung Andreas, Folwaczny Matthias, Yang Dongyun, Ning Yan, Sebio Ana, Stremitzer Stefan, Sunakawa Yu, Matsusaka Satoshi, Yamauchi Shinichi, Loupakis Fotios, Cremolini Chiara, Falcone Alfredo, Lenz Heinz-Josef
Abstract excerpt
Transmembrane receptors, such as the EGFR, are regulated by their turnover, which is dependent on the ubiquitin-proteasome system. We tested in two independent study cohorts whether SNPs in genes involved in EGFR turnover predict clinical outcome in cetuximab-treated metastatic colorectal cancer (mCRC) patients. The following SNPs involved in EGFR degradation were analyzed in a screening cohort of 108 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
